Evidence of a M1-muscarinic GPCR homolog in unicellular eukaryotes: featuring Acanthamoeba spp bioinformatics 3D-modelling and experimentations

@article{Baig2017EvidenceOA,
  title={Evidence of a M1-muscarinic GPCR homolog in unicellular eukaryotes: featuring Acanthamoeba spp bioinformatics 3D-modelling and experimentations},
  author={Abdul Mannan Baig and Hakimuddin Razi Ahmad},
  journal={Journal of Receptors and Signal Transduction},
  year={2017},
  volume={37},
  pages={267 - 275}
}
  • A. BaigH. R. Ahmad
  • Published 4 May 2017
  • Biology
  • Journal of Receptors and Signal Transduction
Abstract Acetylcholine affects the target cellular function via muscarinic and nicotinic cholinergic receptors that are seen to exist in humans. Both the cholinergic receptors are G-protein coupled receptors (GPCRs) that perform cardinal functions in humans. Anti-muscarinic drugs, particularly the ones that target M1 subtype (mAChR1), have consistently shown to kill unicellular pathogenic eukaryotes like Acanthamoeba spp. As the M1 receptor subtype has not been reported to be expressed in the… 

Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp.

Evidence is provided for the presence of homology of evolutionary conserved key enzymes of the cholinergic system like choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) in A. castellanii spp.

Forte of Bioinformatic Computational Tools in Identification of Targets of Digitalis in Unicellular Eukaryotes: Featuring Acanthamoeba Castellanii

The target proteins in Acanthamoeba are similar to the cellular targets of digoxin in humans, and 3D structural modelling, ligand binding predictions, and experimental assays show that A. castellanii do express a similar P-type ATPase.

Neuroleptic Drug Targets a Brain-Eating Amoeba: Effects of Promethazine on Neurotropic Acanthamoeba castellanii.

Promethazine and its structural analogs, because of being FDA-approved, have a wider margin of safety that can be tested as potential anti- Acanthamoeba agents in diseases like keratitis and encephalitis caused by this protist pathogen.

Characterization of nAChRs in Nematostella vectensis supports neuronal and non-neuronal roles in the cnidarian–bilaterian common ancestor

Examination of the spatiotemporal expression of N. vectensis nAChRs during development and in juvenile polyps identified that NvnA ChRs are expressed in neurons, muscles, gonads, and large domains known to be consistent with a role in developmental patterning, supporting a neuronal function for acetylcholine in cnidarians.

Stimulatory and Toxic Effects of Neurotransmitters on the lux Operon-Dependent Bioluminescence of Escherichia coli K12 TGI

A regulatory, presumably receptor-dependent, effect is exerted by the tested neurochemicals on the bacterium E. coli K12 TGI, in an analogy to their impact on nervous, immune, and other specialized types of eukaryotic cells.

Is There a Cholinergic Survival Incentive for Neurotropic Parasites in the Brain?

  • A. Baig
  • Biology
    ACS chemical neuroscience
  • 2017
This work studied the possible chemicals of neural origin that can lure the parasite toward the brain, enabling them to cause meningoencephalitis, and identified those that can prevent cerebral infection and provide ample time to eradicate the parasites at the primary site of infection.

Drug Target Discovery Methods In Targeting Neurotropic Parasitic Amoebae.

This Viewpoint attempts to highlight the novel methodologies that use drug assays and structural modeling to uncover cellular targets of diverse groups of drugs and the safety issues of the drugs proposed for their use in brain infections caused by the neurotropic parasitic amoebae.

Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae.

  • A. Baig
  • Biology, Medicine
    Current drug targets
  • 2019
Out-lines the bioinformatics methodologies that can be used in the discovery of such novel drug-targets, their chronicle by in-vitro assays done in the past and the translational value of such target discoveries in human diseases caused by FLA.

Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications

Recent discoveries of cell surface receptors and druggable proteins in pathogenic variants of Acanthamoeba castellanii have revived the interest of repurposing of some anticholinergic drugs like atropine that are already used in non-infectious ocular disorders.

References

SHOWING 1-10 OF 28 REFERENCES

Two types of muscarinic acetylcholine receptors in Drosophila and other arthropods

This study cloned two structurally related GPCRs from the fruit fly Drosophila melanogaster, which, after expression in Chinese hamster ovary cells, proved to be muscarinic acetylcholine receptors, and proposed a model for the evolution of mAChRs.

Crystal structures of the M1 and M4 muscarinic acetylcholine receptors

Comparison of crystal structures of the M1 and M4 muscarinic receptors bound to the inverse agonist, tiotropium, reveals differences in the orthosteric and allosteric binding sites that contribute to a role in drug selectivity at this important receptor family.

RpkA, a Highly Conserved GPCR with a Lipid Kinase Domain, Has a Role in Phagocytosis and Anti-Bacterial Defense

It is shown by immunofluorescence that RpkA localizes to endosomal membranes and is specifically recruited to phagosomes, a component of the defense system of D. discoideum as well as other lower eukaryotes.

Monoclonal antibodies detect the conservation of muscarinic cholinergic receptor structure from Drosophila to human brain and detect possible structural homology with alpha 1-adrenergic receptors.

The data indicate that muscarinic receptors are highly conserved over a considerable evolutionary period, and suggest that some degree of structural homology exists between mus carinic cholinergic receptors and alpha 1-adrenergic receptors.

In Vitro Efficacies of Clinically Available Drugs against Growth and Viability of an Acanthamoeba castellanii Keratitis Isolate Belonging to the T4 Genotype

The clinically available drugs tested in this study represent potential agents for managing keratitis and granulomatous amoebic encephalitis caused by Acanthamoeba spp.

Allosteric activation of the CaR by L-amino acids.

  • B. Kobilka
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2000
The investigators demonstrate that the extracellular calcium receptor is also capable of detecting physiologic levels of specific l-amino acids, which has interesting implications for the coordinate regulation of Ca2+ homeostasis and amino acid metabolism.

Muscarinic receptor agonists and antagonists: effects on cancer.

  • E. Spindel
  • Biology, Medicine
    Handbook of experimental pharmacology
  • 2012
The ability of muscarinic agonists to stimulate, and M3 antagonists to inhibit tumor growth has clearly been demonstrated for lung and colon cancer, and the potential role of these drugs as adjuvants to current cancer therapies is supported.

The Phyre2 web portal for protein modeling, prediction and analysis

An updated protocol for Phyre2, which uses advanced remote homology detection methods to build 3D models, predict ligand binding sites and analyze the effect of amino acid variants for a user's protein sequence.

Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease

  • J. Yakel
  • Biology, Psychology
    Pflügers Archiv - European Journal of Physiology
  • 2012
This work has focused on the role of the nAChRs in regulating hippocampal function, from understanding the expression and functional properties of the various subtypes of nA cholinergic receptors, and what role these receptors may be playing in regulating synaptic plasticity.